Hear the latest breakthroughs and technologies for biomarker and CDx development, case studies for gaining regulatory approval, and commercialisation strategies.
Position yourself alongside other IVD, biomarker, multi-omics, and digital pathology solution providers, showcasing your capabilities to a room full of pharmaceutical leaders.
Unite with your fellow industry leaders and academic pioneers advancing precision medicine within Japan and globally to progress the future of streamlined CDx co-development.